Sebastian Joyce

Sebastian Joyce

Auto-generated profile, based on publicly available information

Sebastian Joyce

Tennessee Valley Healthcare System

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2000 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MKMary K. Kennedy
Mary K. Kennedy
MGMoira Glaccum
Moira Glaccum
SBSandra N. Brown
Sandra N. Brown
EBEric A. Butz
Eric A. Butz
JVJoanne L. Viney
Joanne L. Viney
JPJacques J. Peschon
Jacques J. Peschon
C57BL/6 mice genetically deficient in interleukin 15 (IL-15−/− mice) were generated by gene targeting. IL-15−/− mice displayed marked reductions in numbers of thymic and peripheral natural killer (NK) T cells, memory phenotype CD8+ T cells, and distinct subpopulations of intestinal intraepithelial lymphocytes (IELs). The reduction but not absence of these populations in IL-15−/− mice likely reflects an important role for IL-15 for expansion and/or survival of these cells. IL-15−/− mice lacked NK cells, as assessed by both immunophenotyping and functional criteria, indicating an obligate role for IL-15 in the development and functional maturation of NK cells. Specific defects associated with IL-15 deficiency were reversed by in vivo administration of exogenous IL-15. Despite their immunological defects, IL-15−/− mice remained healthy when maintained under specific pathogen-free conditions. However, IL-15−/− mice are likely to have compromised host defense responses to various pathogens, as they were unable to mount a protective response to challenge with vaccinia virus. These data reveal critical roles for IL-15 in the development of specific lymphoid lineages. Moreover, the ability to rescue lymphoid defects in IL-15−/− mice by IL-15 administration represents a powerful means by which to further elucidate the biological roles of this cytokine.

1 April 1997 in Immunity
Verified
Journal Article
Closed access
SMSanjeev K Mendiratta
Sanjeev K Mendiratta
WMW.David Martin
W.David Martin
SHSeokmann Hong
Seokmann Hong
ABAlina Boesteanu
Alina Boesteanu
SJSebastian Joyce
Sebastian Joyce
Luc Van KaerLuc Van Kaer
Luc Van Kaer

1 June 2010 in Immunity
Verified
Journal Article
Closed access
KLKeunwook Lee
Keunwook Lee
PGPrathyusha Gudapati
Prathyusha Gudapati
SDSrdjan Dragovic
Srdjan Dragovic
CSCharles Spencer
Charles Spencer
SJSebastian Joyce
Sebastian Joyce
MBMark Boothby
Mark Boothby

25 August 2005 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
VPVrajesh V. Parekh
Vrajesh V. Parekh
MWMichael T. Wilson
Michael T. Wilson
DODanyvid Olivares-Villagómez
Danyvid Olivares-Villagómez
ASAvneesh K. Singh
Avneesh K. Singh
LWLan Wu
Lan Wu
Luc Van KaerLuc Van Kaer
Luc Van Kaer
Natural killer T (NKT) cells recognize glycolipid antigens presented by the MHC class I–related glycoprotein CD1d. The in vivo dynamics of the NKT cell population in response to glycolipid activation remain poorly understood. Here, we show that a single administration of the synthetic glycolipid α-galactosylceramide (α-GalCer) induces long-term NKT cell unresponsiveness in mice. NKT cells failed to proliferate and produce IFN-γ upon α-GalCer restimulation but retained the capacity to produce IL-4. Consequently, we found that activation of anergic NKT cells with α-GalCer exacerbated, rather than prevented, B16 metastasis formation, but that these cells retained their capacity to protect mice against experimental autoimmune encephalomyelitis. NKT cell anergy was induced in a thymus-independent manner and maintained in an NKT cell–autonomous manner. The anergic state could be broken by IL-2 and by stimuli that bypass proximal TCR signaling events. Collectively, the kinetics of initial NKT cell activation, expansion, and induction of anergy in response to α-GalCer administration resemble the responses of conventional T cells to strong stimuli such as superantigens. Our findings have important implications for the development of NKT cell–based vaccines and immunotherapies.

6 March 1998 in Science
Verified
Journal Article
Closed access
PDF file
SJSebastian Joyce
Sebastian Joyce
AWAmina S. Woods
Amina S. Woods
JYJonathan W. Yewdell
Jonathan W. Yewdell
JBJack R. Bennink
Jack R. Bennink
ASA. Dharshan De Silva
A. Dharshan De Silva
RBRandy R. Brutkiewicz
Randy R. Brutkiewicz
Mouse CD1d1, a member of the CD1 family of evolutionarily conserved major histocompatibility antigen–like molecules, controls the differentiation and function of a T lymphocyte subset, NK1 + natural T cells, proposed to regulate immune responses. The CD1d1 crystal structure revealed a large hydrophobic binding site occupied by a ligand of unknown chemical nature. Mass spectrometry and metabolic radiolabeling were used to identify cellular glycosylphosphatidylinositol as a major natural ligand of CD1d1. CD1d1 bound glycosylphosphatidylinositol through its phosphatidylinositol aspect with high affinity. Glycosylphosphatidylinositol or another glycolipid could be a candidate natural ligand for CD1d1-restricted T cells.

17 December 2001 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ASAvneesh K. Singh
Avneesh K. Singh
MWMichael T. Wilson
Michael T. Wilson
SHSeokmann Hong
Seokmann Hong
DODanyvid Olivares-Villagómez
Danyvid Olivares-Villagómez
CDCaigan Du
Caigan Du
Luc Van KaerLuc Van Kaer
Luc Van Kaer
Experimental autoimmune encephalomyelitis (EAE) serves as a prototypic model for T cell–mediated autoimmunity. Vα14 natural killer T (NKT) cells are a subset of T lymphocytes that recognize glycolipid antigens presented by the nonpolymorphic major histocompatibility complex (MHC) class I–like protein CD1d. Here, we show that activation of Vα14 NKT cells by the glycosphingolipid α-galactosylceramide (α-GalCer) protects susceptible mice against EAE. β-GalCer, which binds CD1d but is not recognized by NKT cells, failed to protect mice against EAE. Furthermore, α-GalCer was unable to protect CD1d knockout (KO) mice against EAE, indicating the requirement for an intact CD1d antigen presentation pathway. Protection of disease conferred by α-GalCer correlated with its ability to suppress myelin antigen-specific Th1 responses and/or to promote myelin antigen-specific Th2 cell responses. α-GalCer was unable to protect IL-4 KO and IL-10 KO mice against EAE, indicating a critical role for both of these cytokines. Because recognition of α-GalCer by NKT cells is phylogenetically conserved, our findings have identified NKT cells as novel target cells for treatment of inflammatory diseases of the central nervous system.